Transparency Needed for Economic Analyses of PA Programs

Transparency Needed for Economic Analyses of PA Programs Dear Editor, I am writing in response to the article Pharmacoeconomic Modeling of Prior-Authorization Intervention for COX-2 Specific Inhibitors in a 3-Tier Copay Plan in the July/August 2003 issue of the Journal of Managed Care Pharmacy. 1 Wh...

Descripción completa

Detalles Bibliográficos
Autor principal: Holdford, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437270/
https://www.ncbi.nlm.nih.gov/pubmed/14664672
http://dx.doi.org/10.18553/jmcp.2003.9.6.576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437270/
https://www.ncbi.nlm.nih.gov/pubmed/14664672
http://dx.doi.org/10.18553/jmcp.2003.9.6.576

Ejemplares similares